| Financial Year |
March 31 2023 |
| Monetary Funds |
8,912,237,162.43 |
| Held-for-trading Financial Assets |
191,459,212.97 |
| Notes Receivable |
-- |
| Accounts Receivable |
6,819,108,274.23 |
| Advances to Suppliers |
619,402,803.41 |
| Other Receivables |
230,993,913.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
104,508,664.57 |
| Inventories |
10,004,086,124.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,654,515,545.18 |
| Total Current Assets |
30,499,227,163.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
59,479,318.19 |
| Long-term Equity Investment |
10,885,531,267.15 |
| Investment Properties |
-- |
| Fixed Assetes |
4,939,584,942.22 |
| Under-construction Projects |
11,635,183,267.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
15,005,889,192.98 |
| R&D expenses |
-- |
| Goodwill |
17,615,150.54 |
| Long-Term Deferred and Prepaid Expenses |
109,902,951.37 |
| Deferred Income Tax Assets |
912,212,036.13 |
| Other Non-Current Assets |
728,881,091.09 |
| Sub-Total of Non-Current Assets |
50,434,180,347.66 |
| Total Assets |
80,933,407,511.25 |
| Short-Term Loans |
2,906,595,269.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,877,657,051.24 |
| Accounts Payable |
3,438,684,664.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
289,262,282.15 |
| Taxes Payable |
1,349,072,599.33 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
304,607,437.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,143,926,858.95 |
| Other Current Liabilities |
74,075,403.17 |
| Sub-Total of Current Liabilities |
12,953,692,359.83 |
| Long-term Loans |
14,014,345,214.15 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
2,209,808,289.25 |
| Special Payable |
-- |
| Estimatied Liabilities |
58,321,896.97 |
| Deferred Income Tax Liabilities |
130,217,237.19 |
| Other Non-Current Liabilities |
33,352,720.38 |
| Sub-Total of Non-Current Liabilities |
16,740,149,184.15 |
| Total Liabilities |
29,693,841,543.98 |
| Paid-In Capital(Or Share Stock) |
2,017,103,539.00 |
| Capital Surplus |
12,438,370,731.46 |
| Surplus Reserve |
1,008,518,089.50 |
| LESS:Treasury Stock |
133,153,672.06 |
| Undistributed Profits |
30,462,580,583.10 |
| Minority Stockholder's Interest |
5,022,538,707.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
46,217,027,259.62 |
| Owner's Equity（Stockholder's Equity） |
51,239,565,967.27 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
80,933,407,511.25 |
